Advertisement
Research Article| Volume 12, ISSUE 4, P771-785, December 1992

Limiting Homologous Blood Exposure

DOI:https://doi.org/10.1016/S0272-2712(18)30487-6
Limiting Homologous Blood Exposure
Previous ArticleNew Testing Approaches in Transfusion Medicine
Next ArticleInactivation Of Microbial Contaminants Of Blood Components
      This paper is only available as a PDF. To read, Please Download here.
      Successful limitation of homologous blood transfusion may necessitate multiple strategies and advance planning. Preoperative and intraoperative autologous blood collection may have to be supplemented with hemostatic pharmacologic agents. The use of cytokines is increasing. More efficient use of directed donors can have an important role in blood use. As these expensive and time-consuming techniques become available, a major challenge will be to determine which patients may benefit from or really need them.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Ahn Y.S.
        • Harrington W.J.
        • Simon S.R.
        • et al.
        Danazol for the treatment of idiopathic thrombocytopenic purpura.
        N Engl J Med. 1987; 308: 1396
        • Bommer J.
        • Ritz E.
        • Weinrich T.
        • et al.
        Subcutaneous erythropoietin.
        Lancet. 1988; 2: 406
        • Bovill D.F.
        • Moulton C.W.
        • Jackson W.S.T.
        • et al.
        The efficacy of intraoperative autologous transfusion in major orthopedic surgery: A regression analysis.
        Orthopedis. 1986; 9: 1403
        • Brandt S.J.
        • Peters W.P.
        • Atwater S.K.
        • et al.
        Effect of recombinant human granulocyte macrophage colony stimulating factor on haematopoietic reconstitution after high dose chemotherapy and autologous bone marrow transplantation.
        N Engl J Med. 1988; 318: 869
        • Brecher M.E.
        • Moore S.B.
        • Taswell H.F.
        Minimal-exposure transfusion: A new approach to homologous blood transfusion.
        Mayo Clin Proc. 1988; 63: 903
        • Brito-Babapulle F.
        Therapeutic applications of the myeloid hematopoietic growth factors.
        Transfusion sci. 1991; 12: 25
        • Bull B.S.
        • Bull M.H.
        The salvaged blood syndrome: A sequel to mechanochemical activation of platelets and leukocytes?.
        Blood Cells. 1990; 16: 5
        • Dzik W.H.
        • Jenkins R.
        Use of intraoperative blood salvage during ortho topic liver transplantation.
        Arch Surg. 1985; 120: 946
        • Fischer C.P.
        • Sonda L.P.
        • Diokno A.C.
        Use of cryoprecipitate coagulum in extracting renal calculi.
        Urology. 1980; 15: 6
        • Forbes J.
        • Anderson M.
        • Anderson G.
        • et al.
        Blood transfusion costs: A multicenter study.
        Transfusion. 1991; 31: 318
        • Goodnough L.T.
        • Rudnick S.
        • Price T.H.
        • et al.
        Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy.
        N Engl J Med. 1989; 321: 1163
        • Hallett J.W.
        • Popovsky M.
        • Ilstrup D.
        Minimizing blood transfusion during abdominal aortic surgery: Recent advances in rapid auto transfusion.
        J Vase Surg. 1987; 5: 601
        • Harker L.A.
        • Malpass T.W.
        • Branson H.E.
        • et al.
        Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective granule release.
        Blood. 1980; 56: 824
        • Holmberg L.
        • Nilsson I.M.
        • Borge L.
        • et al.
        Platelet aggregation induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in type II-B von Willebrand’s disease.
        N Engl J Med. 1983; 309: 816
        • Janson P.A.
        • Jubelirer S.J.
        • Weintein M.J.
        • et al.
        Treatment of the bleeding tendency in uremia with cryoprecipitate.
        N Engl J Med. 1980; 303: 1318
        • Keeling M.M.
        • Gray L.A.
        • Brink M.A.
        • et al.
        Intraoperative auto transfusion: Experience in 725 consecutive cases.
        Ann Surg. 1983; 197: 536
        • Kickler T.S.
        • Spivak J.L.
        Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous blood donors.
        JAMA. 1988; 260: 65
        • Mammen E.F.
        • Koets M.H.
        • Washington B.C.
        • et al.
        Hemostasis changes during cardiopulmonary bypass surgery.
        Semin Thromb Hemost. 1985; 11: 281
        • Manno C.S.
        • Wood K.
        • Kim H.C.
        • et al.
        The hemostatic benefit of fresh whole blood after open heart surgery in children.
        Blood. 1989; 74: 100a
        • Mannuci P.M.
        • Frederici A.B.
        • Sirchi G.
        Hemostasis testing during massive blood replacement: A study of 172 cases.
        Vox Sang. 1982; 42: 113
        • McLeod B.C.
        • Sassetti R.J.
        • Cole E.R.
        • et al.
        Long-term frequent plasma exchange donation of cryoprecipitate.
        Transfusion. 1988; 28: 307
        • McLeod B.C.
        • Sassetti R.J.
        • Owns E.A.
        • et al.
        Simultaneous collection of platelets and cryoprecipitate by plasma exchange donation.
        Transfusion. 1989; 29: 332
        • National Institute of Health Consensus Development Conference
        Platelet transfusion therapy.
        JAMA. 1987; 257: 1777
        • Noon G.P.
        • Jones J.
        • Fehir K.
        • et al.
        Use of preoperatively obtained platelets and plasma in patients undergoing cardiopulmonary bypass.
        J Clin Apheresis. 1990; 5: 91
        • Office of Medical Application of Research, National Institute of Health
        Fresh frozen plasma: Indications and risks.
        JAMA. 1985; 253: 551
        • Office of Medical Applications of Research, National Institutes of Health
        Perioperative red cell transfusion.
        JAMA. 1988; 260: 2700
        • Owings D.V.
        • Kruskall M.S.
        • Thurer R.L.
        • et al.
        Autologous blood donations prior to elective cardiac surgery: Safety and effect on subsequent blood use.
        JAMA. 1989; 262: 1963
        • Popovsky M.A.
        • Devine P.A.
        • Taswell H.F.
        Intraoperative autologous transfusion.
        Mayo Clin Proc. 1985; 60: 125
        • Reed R.L.
        • Ciavarella D.
        • Heimback D.M.
        • et al.
        Prophylactic platelet administration during massive transfusion.
        Ann Surg. 1986; 203: 40
        • Reul G.J.
        • Solis R.T.
        • Greenberg S.D.
        • et al.
        Experience with autotransfusion in the surgical management of trauma.
        Surgery. 1974; 76: 546
        • Robicsek F.
        • Duncan G.D.
        • Born G.V.
        • et al.
        Inherent dangers of simultaneous application of microfibrillar collagen hemostat and blood saving devices.
        J Thorac Cardio vase Surg. 1986; 90: 766
        • Rousou J.A.
        • Engelman R.M.
        • Breyer R.H.
        Fibrin glue: An effective hemostatic agent for non-suturable intraoperative bleeding.
        Ann Thorac Surg. 1984; 38: 409
        • Royston D.
        • Bidstrup B.D.
        • Taylor K.M.
        • et al.
        Aprotinin decreases the need for postoperative blood transfusion in patients having open heart surgery.
        Bibl Cardiol. 1988; 43: 73
        • Salzman E.W.
        • Weinstein M.J.
        • Weintraub R.M.
        • et al.
        Treatment with desmopressin acetate to reduce blood loss after cardiac surgery.
        N Engl J Med. 1986; 341: 1402
        • Silberstein L.E.
        • Williams L.J.
        • Huglett M.A.
        • et al.
        An autologous fibrinogen based adhesive for use in otologic surgery.
        Transfusion. 1988; 28: 319
        • Wenger R.K.
        • Lukasiewicz H.
        • Mikuta B.S.
        • et al.
        Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass.
        J Thorac Cardiovasc Surg. 1989; 97: 235
        • Yawn D.H.
        Properties of salvaged blood.
        in: Taswell H.F. Pineda A.A. Autologous Transfusion and Hemotherapy. Blackwell Scientific Publications, Boston1991: 194

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30487-6

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX